A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies

Clinical trial NCT03082209 · COMPLETED

Trial details

NCT number: NCT03082209
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Cancer Hematologic Malignancies

Start date: 2017-03-20
Primary completion: 2022-01-21
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.